SCHEMBL3067489

SCHEMBL3067489

NC(=O)CCCCCCCCCCCCCCC(=O)O

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.75
LMNA P02545 3/20 0.75
NFKB1 P19838 2/20 0.75
PMP22 Q01453 1/20 0.75
ALDH1A1 P00352 3/20 0.65
MEN1 O00255 2/20 0.65
ALOX15 P16050 2/20 0.65
KMT2A Q03164 2/20 0.65
PLG P00747 1/20 0.65
THRB P10828 1/20 0.65
SLC6A2 P23975 1/20 0.65
RECQL P46063 1/20 0.65
SLC6A3 Q01959 1/20 0.65
GPR84 Q9NQS5 8/20 0.60
FFAR1 O14842 2/20 0.60
FFAR4 Q5NUL3 2/20 0.60
CYP2D6 P10635 1/20 0.60
SLC22A6 Q4U2R8 2/20 0.59
PPARG P37231 6/20 0.57
PPARD Q03181 6/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7603870 1.00 TSHR (0.75) TSHRLMNANFKB1PMP22ALDH1A1
SCHEMBL19775838 1.00 TSHR (0.75) TSHRLMNANFKB1PMP22ALDH1A1
SCHEMBL125909 1.00 TSHR (0.75) TSHRLMNANFKB1PMP22ALDH1A1
SCHEMBL155418 1.00 TSHR (0.75) TSHRLMNANFKB1PMP22ALDH1A1
SCHEMBL12849553 1.00 TSHR (0.75) TSHRLMNANFKB1PMP22ALDH1A1
SCHEMBL25255715 1.00 TSHR (0.75) TSHRLMNANFKB1PMP22ALDH1A1
SCHEMBL19599369 1.00 TSHR (0.75) TSHRLMNANFKB1PMP22ALDH1A1
SCHEMBL227903 1.00 TSHR (0.75) TSHRLMNANFKB1PMP22ALDH1A1
SCHEMBL20651676 1.00 TSHR (0.75) TSHRLMNANFKB1PMP22ALDH1A1
SCHEMBL4389596 1.00 TSHR (0.75) TSHRLMNANFKB1PMP22ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118079021-A Treatment or amelioration of metabolic disorders using GLP-1 receptor agonists coupled to Gastric Inhibitory Peptide Receptor (GIPR) antagonists 美国安进公司 2024-05-28 CN claimed
WO-2021117860-A1 RESIN MOLDED BODY AND RESIN MOLDED BODY PRODUCTION METHOD 三菱ケミカル株式会社 2021-06-17 WO claimed
CN-110662558-A Methods of treating or ameliorating metabolic disorders using GLP-1 receptor agonists coupled to Gastric Inhibitory Peptide Receptor (GIPR) antagonists 美国安进公司 2020-01-07 CN claimed
US-20160183557-A1 DIETARY PASTE COMPOSITIONS FOR RUMINANTS AND METHODS OF MAKING AND USING THE SAME BENEMILK OY (FI) 2016-06-30 US claimed
US-20160183558-A1 RUMINANT FEED COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME BENEMILK OY (FI) 2016-06-30 US claimed
US-20160183559-A1 DIETARY COMPOSITIONS FOR RUMINANTS AND CONTAINERS FOR STORING AND DISPENSING SAME BENEMILK OY (FI) 2016-06-30 US claimed
WO-2015016827-A1 DIETARY COMPOSITIONS FOR RUMINANTS AND CONTAINERS FOR STORING AND DISPENSING SAME BENEMILK OY (FI) 2015-02-05 WO claimed
WO-2015016826-A1 RUMINANT FEED COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME BENEMILK OY (FI) 2015-02-05 WO claimed
WO-2015016823-A1 DIETARY PASTE COMPOSITIONS FOR RUMINANTS AND METHODS OF MAKING AND USING THE SAME BENEMILK OY (FI) 2015-02-05 WO claimed
CN-103906528-A Methods of treating diabetes with sustained release formulations of GLP-1 receptor agonists AMYLIN PHARMACEUTICALS INC 2014-07-02 CN claimed
CN-110831969-B Methods of treating or ameliorating metabolic disorders using a combination of a Gastric Inhibitory Peptide Receptor (GIPR) binding protein and a GLP-1 agonist 安进公司 2024-06-21 CN disclosed
CN-118079021-A Treatment or amelioration of metabolic disorders using GLP-1 receptor agonists coupled to Gastric Inhibitory Peptide Receptor (GIPR) antagonists 美国安进公司 2024-05-28 CN disclosed
CN-113646052-B Reversible thermochromic composition, reversible thermochromic microcapsule pigment, and writing instrument 百乐墨水株式会社 2024-05-17 CN disclosed
CN-110662558-B Treatment or amelioration of metabolic disorders using GLP-1 receptor agonists coupled to Gastric Inhibitory Peptide Receptor (GIPR) antagonists 美国安进公司 2024-04-09 CN disclosed
CN-117106085-A Methods of treating or ameliorating metabolic disorders using combinations of GIPR binding proteins and GLP-1 agonists 美国安进公司 2023-11-24 CN disclosed
EP-0632822-A1 CLEANING COMPOSITIONS WITH GLYCEROL AMIDES. PROCTER & GAMBLE (US) 1995-01-11 EP disclosed
WO-1993019145-A1 CLEANING COMPOSITIONS WITH GLYCEROL AMIDES THE PROCTER & GAMBLE COMPANY (US) 1993-09-30 WO disclosed
US-5223179-A Cleaning compositions with glycerol amides THE PROCTER & GAMBLE COMPANY (US) 1993-06-29 US disclosed
US-RE28957-E Synthetic resin compositions and methods of utilizing the same JOHNSON & JOHNSON (US) 1976-09-07 US disclosed
US-3931085-A POLYVALENT METAL COMPLEX JOHNSON & JOHNSON (US) 1976-01-06 US disclosed